Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kura Oncology Inc. June 5, 202582.3%
-
Kiniksa Pharmaceuticals International plc June 3, 202582.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,799 | — | — |
| Mar 18, 2026 | Kura Oncology Inc. | Option exercise | +10,000 | $3.12 | $31,200 |
| Aug 14, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +18,760 | $15.47 | $290,217 |
| Aug 14, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +33,237 | $14.33 | $476,286 |
| Aug 14, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +26,236 | $15.19 | $398,525 |
| Aug 14, 2025 | Kiniksa Pharmaceuticals International plc | Open-market sale | −78,233 | $33.09 | $2,588,730 |
| Aug 13, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +20,129 | $10.36 | $208,536 |
| Aug 13, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +30,000 | $9.88 | $296,400 |
| Aug 13, 2025 | Kiniksa Pharmaceuticals International plc | Open-market sale | −50,129 | $33.32 | $1,670,298 |
| Aug 12, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +21,959 | $1.86 | $40,844 |
| Aug 12, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +27,448 | $3.80 | $104,302 |
| Aug 12, 2025 | Kiniksa Pharmaceuticals International plc | Open-market sale | −49,407 | $32.40 | $1,600,787 |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +3,173 | — | — |
| Jun 6, 2024 | Kiniksa Pharmaceuticals International plc | Option exercise | +4,373 | — | — |
| Jun 29, 2023 | Kiniksa Pharmaceuticals International plc | Option exercise | +5,000 | — | — |
Questions about Thomas Malley
What boards is Thomas Malley on?
Thomas Malley sits on the boards of BeOne Medicines Ltd., Kiniksa Pharmaceuticals International plc and Kura Oncology Inc.
How long has Thomas Malley served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.